Story perspectives

Pharmaceutical Executive Collapses Amid Drug Cost Announcement

11/9/2025

Summary

Story summary

An unnamed pharmaceutical executive collapsed during a press conference in the Oval Office on November 6, 2025.
The collapse occurred as U.S. President Donald Trump announced a deal to lower obesity drug costs, with Dr. Mehmet Oz assisting.
White House Press Secretary Karoline Leavitt confirmed the executive was okay after receiving medical attention.
The deal aims to make Ozempic and Wegovy more affordable, lowering prices for Medicare and Medicaid patients.

History

Historical Context

The Medicare Prescription Drug, Improvement, and Modernization Act, enacted in 2003, allowed Medicare to provide prescription drug coverage but prohibited it from negotiating prices, impacting affordability for millions. In 2022, the Inflation Reduction Act began allowing Medicare to negotiate drug prices starting in 2026, reflecting ongoing efforts to address the high costs of medications, which reached over $600 billion in 2023.

1 of 2

Story summary

An unnamed pharmaceutical executive collapsed during a press conference in the Oval Office on November 6, 2025.
The collapse occurred as U.S. President Donald Trump announced a deal to lower obesity drug costs, with Dr. Mehmet Oz assisting.
White House Press Secretary Karoline Leavitt confirmed the executive was okay after receiving medical attention.
The deal aims to make Ozempic and Wegovy more affordable, lowering prices for Medicare and Medicaid patients.

1 / 2